BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer
BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way ...
Meta, Pfizer on DOL List of Upcoming Contractor Anti-Bias Audits
Meta Platforms Inc, Pfizer Inc and American Airlines are among the companies the Labor Department’s contractor watchdog has ...
Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’
We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a ...
Pfizer Inc. stock rises Monday, still underperforms market
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Pfizer: High Dividend And Low Price Might Still Offset The Expanding Risks
Pfizer's stock appears undervalued with a high dividend yield of 6.8%, making it a potential long-term investment despite low growth expectations. The company reported strong Q3 results with 31.2% YoY ...
Pfizer Names Chris Boshoff Chief Scientific Officer And President, R&D, Effective Jan.1
Drug major Pfizer Inc. (PFE) announced Wednesday the appointment of Chris Boshoff as Chief Scientific Officer and President, Research ...
Is It Time to Sell Eli Lilly and Pfizer Stocks?
Arguably, no big pharma stocks have dominated the industry more over the last few years than Eli Lilly (NYSE: LLY) and Pfizer ...
Pfizer: The Tide Finally Turning
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
Benzinga.com8d
Stock Of The Day: Is Pfizer Set Up To Rally?
Oversold stocks that drop to support tend to reverse and rally. Pfizer Inc. PFE shares are lower on Thursday due to news ...
Pfizer (NYSE:PFE) stock falls 5.3% in past week as three-year earnings and shareholder returns continue downward trend
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the ...